Arrayjet will provide its Super Marathon Microarrayer to print 100,000 antibodies onto microarray chips for Abmart.
The process will help Abmart move further with pivitol research it is conducting surrounding the use of antibodies.
The Abmart contract is the first deal concluded with APG-Bio also based in Shanghai who have been appointed Arrayjet’s distributor for the Asia Pacific market.
Dr. Zhaohui Wang, senior R&D manager of Abmart explains, partnerships such as this one with Arrayjet are vital for its continued success.
Dr. Wang further commented: "The reason we chose Arrayjet Super Marathon for production is that we are impressed by its high throughput, superior stability and consistency of printing performance.
"We have had issues with ‘repeatability’ in and between batches on our previous arrayer, so we are looking forward to a satisfying result from our Super Marathon and applying our competitive technology onto microarrays.
"This will minimize the reaction and produce easy-to-use screening tools for researchers so that they can do screening on their own."
Iain McWilliam, CEO at Arrayjet added: "There is a great synergy between our two organisations.
"We have known Abmart and its fantastic work for a long time and equally, they know how Arrayjet can be a significant value – add to their business, providing exceptional accuracy precision and quality they need to create and produce the vast libraries of monoclonal antibodies for its global customer base.
"Moreover, we are delighted to work with them and help to extend our reach across Asia Pacific as well."